1. Home
  2. OGN vs DAN Comparison

OGN vs DAN Comparison

Compare OGN & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.76

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$26.66

Market Cap

3.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
DAN
Founded
1923
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
OGN
DAN
Price
$13.76
$26.66
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$11.25
★ $38.67
AVG Volume (30 Days)
★ 2.0M
1.2M
Earning Date
11-09-2026
10-28-2026
Dividend Yield
0.58%
★ 1.70%
EPS Growth
N/A
★ 264.10
EPS
0.95
★ 9.93
Revenue
$6,216,000,000.00
★ $7,500,000,000.00
Revenue This Year
N/A
$3.78
Revenue Next Year
$2.51
$48.29
P/E Ratio
$14.48
★ $2.85
Revenue Growth
★ N/A
N/A
52 Week Low
$5.69
$18.96
52 Week High
$13.83
$39.56

Technical Indicators

Market Signals
Indicator
OGN
DAN
Relative Strength Index (RSI) 54.03 36.44
Support Level $13.46 $26.07
Resistance Level $13.77 $28.05
Average True Range (ATR) 0.04 0.94
MACD -0.00 -0.03
Stochastic Oscillator 34.78 13.04

Price Performance

Historical Comparison
OGN
DAN

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About DAN Dana Incorporated

Dana Inc is provider of products to virtually every vehicle manufacturer in the world. Its technologies include drive systems (axles, driveshafts and transmissions); electrodynamic technologies (motors, inverters, software and control systems, battery-management systems, and fuel cell plates); sealing solutions (gaskets, seals, cam covers, and oil pan modules); thermal-management technologies (transmission and engine oil cooling, battery and electronics cooling, charge air cooling, and thermal-acoustical protective shielding); and digital solutions (active and passive system controls and descriptive and predictive analytics). The company has two operating segments: Light Vehicle and Commercial Vehicle. The Light Vehicles segment generates the majority of revenue.

Share on Social Networks: